CommercialPrior AuthHigh impact
Rituximab (CPB 0314, reviewed 2026-01-08)
Aetna·Oncology, Hematology, Rheumatology +5 more·Medical Policy
Effective date
Jan 8, 2026
We identified it
Aug 16, 2026
Summary
Aetna has updated its Rituximab (CPB 0314) medical policy, effective 2026-01-08. This policy establishes coverage criteria for rituximab products (Rituxan, Truxima, Riabni, Ruxience) across hematologic, oncologic, rheumatologic, and autoimmune conditions. ALL rituximab administration requires precertification, and site-of-care utilization management applies to infusion settings. Billing teams must verify prior authorization before claims submission and confirm prescriber specialty alignment with policy requirements.
Action Required
IMMEDIATE ACTIONS REQUIRED: (1) Billing team must implement mandatory precertification process for ALL rituximab products (Rituxan, Truxima, Riabni, Ruxience, Rituxan Hycela) before claim submission. Contact Aetna precertification at (866) 752-7021 or fax (888) 267-3277. (2) Update billing system to reject claims without precertification approval documentation and flag for denial prevention. (3) Providers must document that prescriber specialty matches policy requirements: rheumatology/immunology/nephrology for RA and vasculitis; neurology for MS/NMOSD/myasthenia gravis; dermatology for blistering diseases; hematology for specific blood disorders. (4) For RA patients: verify prior biologic/targeted synthetic drug use OR biomarker testing (RF, anti-CCP) plus inadequate MTX response (3+ months at ≥15 mg/week) is documented before approval. (5) For oncology: confirm CD20-positive B-cell malignancy diagnosis is documented in medical record. (6) Enforce exclusion rules in billing system: block claims combining rituximab with other biologics for RA, other MS disease-modifying agents, or other biologics for neuromyelitis optica. (7) Implement site-of-care utilization management per Aetna policy for infusion venues. (8) Front desk and authorization teams must update encounter forms to include precertification checklist and specialty confirmation fields. Failure to obtain precertification will result in claim denials.